Industry NewsAbivax’s COVID-19 phase 2b/3 trial with ABX464 declared research national priority by the French government’s clinical trial council
Industry NewsSygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities
Expert InsightsHPLC and UHPLC reversed-phase method development - Selecting a reproducible starting point